Keith F. McDaniel

2.2k total citations
37 papers, 861 citations indexed

About

Keith F. McDaniel is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Keith F. McDaniel has authored 37 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 14 papers in Infectious Diseases and 14 papers in Molecular Biology. Recurrent topics in Keith F. McDaniel's work include HIV/AIDS drug development and treatment (14 papers), Protein Degradation and Inhibitors (8 papers) and Hepatitis C virus research (8 papers). Keith F. McDaniel is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), Protein Degradation and Inhibitors (8 papers) and Hepatitis C virus research (8 papers). Keith F. McDaniel collaborates with scholars based in United States, United Kingdom and Japan. Keith F. McDaniel's co-authors include Peter J. Harrington, Louis S. Hegedus, Dale J. Kempf, Warren M. Kati, Akhteruzzaman Molla, Clarence J. Maring, Debra Montgomery, Yu Shen, Tamar Uziel and William E. Kohlbrenner and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Keith F. McDaniel

36 papers receiving 826 citations

Peers

Countries citing papers authored by Keith F. McDaniel

Since Specialization

Citations

This map shows the geographic impact of Keith F. McDaniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith F. McDaniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith F. McDaniel more than expected).

Fields of papers citing papers by Keith F. McDaniel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith F. McDaniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith F. McDaniel. The network helps show where Keith F. McDaniel may publish in the future.

Co-authorship network of co-authors of Keith F. McDaniel

This figure shows the co-authorship network connecting the top 25 collaborators of Keith F. McDaniel. A scholar is included among the top collaborators of Keith F. McDaniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith F. McDaniel. Keith F. McDaniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Physics-Based Ensemble Modeling Approach That Utilizes 3D Molecular Conformation and Packing to Access Aqueous Thermodynamic Solubility: A Case Study of Orally Available Bromodomain and Extraterminal Domain Inhibitor Lead Optimization Series 2021 ·Journal of Chemical Information and Modeling ·Richard S. Hong, Alessandra Mattei, Ahmad Y. Sheikh, Rajni M. Bhardwaj, Michael A. Bellucci, Keith F. McDaniel, (unknown), Guangxu Sun, (unknown), Lingle Wang, Sayan Mondal, Jianguo Ji, Thomas B. Borchardt	18
2	Preclinical evidence for management of thrombocytopenia associated with bromodomain extra-terminal (BET) inhibition therapy. 2018 ·Journal of Clinical Oncology ·Srinivasa R. Mantena, (unknown), Scott W. Mittelstadt, (unknown), (unknown), Keith F. McDaniel, Stormy L. Koeniger, Johannes Wolff	3
3	Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075 2016 ·Molecular Cancer Research ·Emily J. Faivre, Denise Wilcox, Xia Li, Paul Hessler, Maricel Torrent, Wei He, Tamar Uziel, Daniel H. Albert, Keith F. McDaniel, Warren M. Kati, Yu Shen	53
4	HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues 2016 ·Molecular Cancer Therapeutics ·Xiaoyu Lin, Xiaoli Huang, Tamar Uziel, Paul Hessler, Daniel H. Albert, Lisa Roberts-Rapp, Keith F. McDaniel, Warren M. Kati, Yu Shen	45
5	In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450 2014 ·Antimicrobial Agents and Chemotherapy ·Edward Tam, Rakesh Tripathi, Daniel E. Cohen, (unknown), Tatyana Dekhtyar, Liangjun Lu, Thomas Reisch, Michelle Irvin, Todd A. Hopkins, Ron Pithawalla, Timothy Middleton, Teresa I. Ng, Keith F. McDaniel, Yat Sun Or, Rajeev Menon, Dale J. Kempf, Akhteruzzaman Molla, Christine A. Collins	102
6	Novel Hepatitis C virus replicon inhibitors: Synthesis and structure–activity relationships of fused pyrimidine derivatives 2012 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger, Darold L. Madigan, David W. A. Beno, David A. Betebenner, Robert J. Carrick, (unknown), Wenping He, Dachun Liu, Clarence J. Maring, Keith F. McDaniel, Hongmei Mo, Akhteruzzaman Molla, (unknown), Edward Tam, Michael D. Tufano, Dale J. Kempf	25
7	Synthesis of potent pyrrolidine influenza neuraminidase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger, Yibo Xu, Warren M. Kati, Dale J. Kempf, Clarence J. Maring, Keith F. McDaniel, Akhteruzzaman Molla, Debra Montgomery, William E. Kohlbrenner	15
8	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives 2007 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger, Darold L. Madigan, (unknown), Douglas K. Hutchinson, (unknown), Warren M. Kati, Yaya Liu, Clarence J. Maring, Sherie Masse, Keith F. McDaniel, Tim Middleton, Hongmei Mo, Akhteruzzaman Molla, Debra Montgomery, Teresa I. Ng, Dale J. Kempf	17
9	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd W. Rockway, Rong Zhang, Dachun Liu, David A. Betebenner, Keith F. McDaniel, John K. Pratt, David W. A. Beno, Debra Montgomery, (unknown), Sherie Masse, Warren M. Kati, Tim Middleton, Akhteruzzaman Molla, Clarence J. Maring, Dale J. Kempf	22
10	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger, Darold L. Madigan, Wen Jiang, Warren M. Kati, Dachun Liu, Yaya Liu, Clarence J. Maring, Sherie Masse, Keith F. McDaniel, Tim Middleton, Hongmei Mo, Akhteruzzaman Molla, Debra Montgomery, John K. Pratt, Todd W. Rockway, Rong Zhang, Dale J. Kempf	24
11	Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines 2005 ·Bioorganic & Medicinal Chemistry Letters ·John K. Pratt, (unknown), Keith F. McDaniel, Clarence J. Maring, Warren M. Kati, Hongmei Mo, Tim Middleton, Yaya Liu, Teresa I. Ng, (unknown), Rong Zhang, Debra Montgomery, Akhteruzzaman Molla, Dale J. Kempf, William E. Kohlbrenner	28
12	Design and synthesis of pseudo-Symmetric HIV protease inhibitors containing a novel hydroxymethylcarbonyl (HMC)-Hydrazide isostere 2003 ·Bioorganic & Medicinal Chemistry Letters ·Koushi Hidaka, Tooru Kimura, Yoshio Hayashi, Keith F. McDaniel, Tatyana Dekhtyar, (unknown), Yoshiaki Kiso	9
13	Preparation and Diazodecomposition Reaction of an α-Diazocarbonyl-Tethered Tricarbonyl(η⁴-cyclohexadiene)iron Complex 1996 ·The Journal of Organic Chemistry ·(unknown), (unknown), Keith F. McDaniel, Mark C. McMills, Arnold L. Rheingold, Glenn P. A. Yap	11
14	Reaction of tricarbonyl(η6-cycloheptatrienyl)manganese with zinc-copper coupling reagents 1995 ·Tetrahedron Letters ·Young Kook Yun, Keith F. McDaniel	3
15	A new preparation of tricarbonyl(η5-pentadienyl) manganese 1993 ·Journal of Organometallic Chemistry ·Keith F. McDaniel, (unknown)	2
16	Nucleophilic attack at C2 of neutral (.eta.5-pentadienyl)manganese complexes: formation of .sigma.,.eta.3-manganese complexes 1990 ·Journal of the American Chemical Society ·(unknown), Keith F. McDaniel	19
17	Diels-Alder Reactions of Bicyclic 1,2,4-Triazines: The Conversion of Pyrimido[4,5-]-1,2,4-triazines to Pyrido[2,3-]pyrimidines (5-Deazapteridines) 1987 ·Tetrahedron Letters ·Edward C. Taylor, Keith F. McDaniel, John C. Warner	9
18	Palladium-catalyzed reactions in the synthesis of 3- and 4-substituted indoles. 2. Total synthesis of the N-acetyl methyl ester of (.+-.)-clavicipitic acids 1987 ·Journal of the American Chemical Society ·Peter J. Harrington, Louis S. Hegedus, Keith F. McDaniel	142
19	ChemInform Abstract: SYNTHESIS OF 1‐(P‐CARBOMETHOXYPHENYL)‐3‐PYRROLIDINONE BY A DIELS‐ALDER ROUTE 1984 ·Chemischer Informationsdienst ·(unknown), Keith F. McDaniel, Jerauld S. Skotnicki	8
20	Saponification of dimethyl cis-2,6-diphenyl-4-oxocyclohexane-1,1-dicarboxylate. A reinvestigation 1982 ·The Journal of Organic Chemistry ·(unknown), John Hohneker, Keith F. McDaniel, David S. Moore	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact